Crucible Therapeutics Limited
Research and experimental development on biotechnology · Sheffield
ActiveUnited KingdomIncorporated 2023Private Limited Company
Financial snapshot
Full financialsPeriod ended 2026-02-28GBPcompany accounts
Net assets
£1.52m+£469.35k vs 2025-02-28Cash at bank
£1.80m+£546.85k vs 2025-02-28Turnover
Not availableNot in extracted metricsEmployees
0.02+0.02 vs 2025-02-28Balance sheet
GBP · companyCompany record
- Company number
- 14690230
- Incorporated
- 2023-02-27
- Legal form
- Private Limited Company
- Registered office
- THE INNOVATION CENTRE, 217 PORTOBELLO, SHEFFIELD, S1 4DP
- SIC codes
- 72110
People & control
View all7Current role holders2Control records without an end date0Outstanding security records
OfficerOther current roles
Clifford Hollowaydirector
0Samantha Jane Macrosecretary
0James Gibbonsdirector
3Neill Mackenziedirector
3Juliet Livadiotisdirector
0Jonathan Foleydirector
1Northern Gritstone Limited · Argobio S.A.S.
Activity timeline
- Clifford Holloway appointed
director
- Accounts period ended
GBP · 111 source facts
- Samantha Jane Macro appointed
secretary
- Ross Mcmaster resigned
secretary
- James Gibbons appointed
director
- Marion Bernard resigned
director
Connected companies
Open networkNo downstream companies resolved. Upstream control, where available, is shown in the network.
Capital & security
Public records and extracted accounts. Missing figures are unknown, not zero. Research matches are not necessarily direct awards.